A. Srikrishna et al. / Tetrahedron Letters 48 (2007) 4087–4090
4089
chlorochromate (PCC) and silica gel in methylene chlo-
ride furnished 3,4,4-trisallylcarvone 6 in 79% yield.
Attempted RCM reaction of trisallylcarvone 6 with
the first generation Grubbs’ catalyst, contrary to our
expectation, furnished a complex mixture. On the other
hand, RCM reaction of trisallylcarveol 9 with Grubbs’
first generation catalyst furnished the targeted tricyclic
system 10, albeit in low yield, whose structure was estab-
lished from spectral data (Scheme 2).
11 in 99% yield. Sonochemically accelerated Barbier
reaction of spiroenone 11 with zinc and allyl bromide
generated tert-alcohol 12, in quantitative yield, which
on oxidation with PCC and silica gel furnished enone
13. Although reaction of enone 13 was found to be
unsuccessful, alcohol 12 underwent a smooth ROM-
RCM reaction. Thus, refluxing a 0.01 M methylene
chloride solution of alcohol 12 and 10 mol % of the
Grubbs’ first generation catalyst for 12 h furnished the
targeted tricyclic system 10 in 76% yield. Oxidation with
PCC and silica gel transformed alcohol 10 into enone
14 in 78% yield, whose structure was established from
spectral data (Scheme 3).
It was then conceived that a two stage metathesis
sequence might control the reaction and improve the
formation of the tricyclic compound 10. Accordingly,
a ROM-RCM strategy was explored via spiroenone
11. Thus, RCM reaction of bisallylcarvone 7 with
Grubbs’ first generation catalyst furnished spiroenone
In summary, we have developed an efficient enantiospec-
ific methodology for the synthesis of the tricyclic ring
system present in the elisabethin diterpenes (which is
also present in colombiasins, cumbiasins and elisaptero-
sins), starting from the readily and abundantly available
monoterpene (R)-carvone. A ROM-RCM sequence was
employed for the simultaneous generation of the B- and
C-rings. Currently, we are investigating the extension of
the methodology for the total synthesis of the elisabe-
thin natural products and their analogues for evaluating
their biological potential.
Yields refer to isolated and chromatographically pure compounds.
All the compounds exhibited spectral data (IR, 1H and 13C NMR and
HRMS) consistent with their structures. Selected spectral data for
26
(5R)-3,4,4-trisallyl-5-isopropenyl-2-methylcyclohex-2-enone 6: ½aꢁD
+91.2 (c 2.5, CHCl3); IR (neat): mmax/cmꢀ1 1668, 1635, 1606, 912;
1H NMR (300 MHz, CDCl3+CCl4) d 5.88–5.57 (3H, m), 5.20–5.00
(6H, m), 4.93 (1H, br s), 4.85 (1H, br s), 3.20–3.00 (2H, m), 2.79 (1H,
dd, J 9.0 and 6.0 Hz), 2.65–2.30 (6H, m), 1.85 (3H, s), 1.74 (3H, s);
13C NMR (75 MHz, CDCl3+CCl4): d 197.6 (C), 157.3 (C), 145.1 (C),
135.3 (C), 135.0 (CH), 134.6 (CH), 134.3 (CH), 118.4 (CH2), 117.8
(CH2), 117.5 (CH2), 115.9 (CH2), 47.2 (CH), 46.6 (C), 42.5 (CH2),
39.7 (CH2), 39.2 (CH2), 35.7 (CH2), 23.2 (CH3), 12.1 (CH3); HRMS:
m/z calcd for C19H26ONa (M+Na): 293.1881; found, 293.1873.
Acknowledgement
25
(10R)-10-Isopropenyl-7-methylspiro[4.5]dec-2,7-dien-6-one 11: ½aꢁD
We thank the Council of Scientific and Industrial
Research, New Delhi, for the award of research fellow-
ships to V.H.P. and G.S.
ꢀ179.2 (c 1.3, CHCl3); IR (neat): mmax/cmꢀ1 1670, 895; 1H NMR
(300 MHz, CDCl3+CCl4): d 6.52 (1H, br s), 5.60 and 5.49 (2H, 2 · dt,
J 6.0 and 2.1 Hz), 4.76 (1H, s), 4.62 (1H, s), 2.90–2.25 (7H, m), 1.79
(3H, s), 1.64 (3H, s); 13C NMR (75 MHz, CDCl3+CCl4): d 200.9 (C),
146.4 (C), 140.8 (CH), 134.0 (C), 129.4 (CH), 127.0 (CH), 114.0
(CH2), 54.5 (C), 51.8 (CH), 41.8 (CH2), 37.8 (CH2), 29.0 (CH2), 22.0
(CH3), 16.9 (CH3); HRMS: m/z calcd for C14H18ONa (M+Na):
225.1255; found, 225.1257. (6S,10R)-6-Allyl-10-isopropenyl-7-meth-
References and notes
1. Rodriguez, A. D. Tetrahedron 1995, 51, 4571, and refer-
ences cited therein.
24
ylspiro[4.5]deca-2,7-dien-6-ol 12: ½aꢁD +2.96 (c 2.7, CHCl3); IR
(neat):
m
max/cmꢀ1 3573, 1633, 893; 1H NMR (300 MHz,
2. Rodriguez, A. D.; Gonzalez, E.; Huang, S. D. J. Org.
Chem. 1998, 63, 7083; Rodriguez, A. D.; Ramirez, C. Org.
Lett. 2000, 2, 507; Rodriguez, A. D.; Ramirez, C.; Rodri-
guez, I. I.; Barnes, C. L. J. Org. Chem. 2000, 65, 1390;
Rodriguez, A. D.; Ramirez, C.; Medina, V.; Shi, Y.-P.
Tetrahedron Lett. 2000, 41, 5177; Rodriguez, A. D.;
Ramirez, C.; Shi, Y.-P. J. Org. Chem. 2000, 65, 6682;
Rodriguez, A. D.; Shi, Y.-P. Tetrahedron 2000, 56, 9015;
Shi, Y.-P.; Rodriguez, I. I.; Rodriguez, A. D. Tetrahedron
Lett. 2003, 44, 3249; See also: Ata, A.; Win, H. Y.; Holt,
D.; Holloway, P.; Segstro, E. P.; Jayatilake, G. S. Helv.
Chim. Acta 2004, 87, 1090.
3. For approaches as well as total syntheses of elisapterosins,
cumbiasins and colombiasins, see: Kraus, G. A.; Kim, J.
Tetrahedron Lett. 2006, 47, 7797; Davies, H. M. L.; Dai, X.;
Long, M. S. J. Am. Chem. Soc. 2006, 128, 2485; Boezio, A.
A.; Jarvo, E. R.; Lawrence, B. M.; Jacobsen, E. N. Angew.
Chem., Int. Ed. 2005, 44, 6046; Jarvo, E. R.; Lawrence, B.
M.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2005, 44, 6043;
Harrowven, D. C.; Pascoe, D. D.; Demurtas, D.; Bourne,
H. O. Angew. Chem., Int. Ed. 2005, 44, 1221; Chaplin, J. H.;
Edwards, A. J.; Flynn, B. L. Org. Biomol. Chem. 2003,
1842; Kim, A. I.; Rychnovsky, S. D. Angew. Chem., Int.
Ed. 2003, 42, 1267; Nicolaou, K. C.; Vassilikogiannakis, G.;
Magerlein, W.; Kranich, R. Chem. Eur. J. 2001, 7,
5359; Harrowven, D. C.; Tyte, M. J. Tetrahedron Lett.
2001, 42, 8709; Nicolaou, K. C.; Vassilikogiannakis, G.;
CDCl3+CCl4): d 5.93 (1H, ddt, J 16.8, 9.0 and 7.2 Hz), 5.68–5.60
(1H, m), 5.60–5.50 (1H, m), 5.34 (1H, br s), 5.17–5.10 (2H, m), 4.72
(1H, s), 4.70 (1H, s), 2.77 (1H, dd, J 11.1 and 6.6 Hz), 2.60–2.20 (8H,
m), 2.05–1.94 (1H, m), 1.71 (3H, s), 1.69 (3H, s); 13C NMR (75 MHz,
CDCl3+CCl4): d 147.2 (C), 139.8 (C), 135.7 (CH), 130.9 (CH), 129.9
(CH), 121.9 (CH), 117.9 (CH2), 114.3 (CH2), 78.0 (C), 52.6 (C), 47.3
(CH), 44.6 (CH2), 37.9 (CH2), 36.5 (CH2), 28.6 (CH2), 20.6 (CH3),
20.0 (CH3); HRMS: m/z calcd for C17H24ONa (M+Na): 267.1725;
found, 267.1721. (1R,5S,9S)-4,8-Dimethyltricyclo[7.4.0.01,5]trideca-3,
24
7,11-trien-9-ol 10: ½aꢁD ꢀ124.0 (c 2.0, CHCl3); IR (neat): mmax/cmꢀ1
3490, 1660, 889; 1H NMR (300 MHz, CDCl3+CCl4): d 5.65 (2H, br
s), 5.45 (1H, m), 5.18 (1H, s), 2.55–1.78 (10H, m), 1.77 (3H, s), 1.64
(3H, s); 13C NMR (75 MHz, CDCl3+CCl4): d 143.4 (C), 143.1 (C),
125.8 (CH), 124.4 (CH), 122.9 (CH), 121.4 (CH), 74.7 (C), 51.1 (C),
50.1 (CH), 44.7 (CH2), 37.0 (CH2), 35.9 (CH2), 26.4 (CH2), 19.0
(CH3), 15.5 (CH3); HRMS: m/z calcd For C15H20ONa (M+Na):
239.1412; found, 239.1404. (1R,5S)-4,8-Dimethyltricy-
26
clo[7.4.0.01,5]trideca-3,8,11-trien-7-one 14: ½aꢁD ꢀ168.3 (c 1.2,
CHCl3); IR (neat): mmax/cmꢀ1 1670, 1622; 1H NMR (300 MHz,
CDCl3+CCl4): d 5.90–5.60 (2H, m, H-11 and 12), 5.21 (1H, br s, H-
3), 3.11 and 2.91 (2H, 2 · d, J 21 Hz), 2.56–2.16 (7H, m), 1.75 (3H, s)
and 1.68 (3H, s) [2 · olefinic-CH3]; 13C NMR (75 MHz,
CDCl3+CCl4): d 197.8 (C), 154.5 (C), 141.4 (C), 129.2 (C), 126.0
(CH), 124.7 (CH), 122.1 (CH), 51.8 (CH), 46.7 (C), 43.1 (CH2), 39.1
(CH2), 38.0 (CH2), 30.0 (CH2), 14.9 (CH3), 11.4 (CH3); HRMS: m/z
calcd for C15H18ONa (M+Na): 237.1255; found, 237.1250.